Yannick van Sleen

University Medical Center Groningen

Netherlands

Research Interests

Explore related searches

Professors in Netherlands Professors in Immunology Immunology professors in Netherlands

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (15)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (6)

Jacoba Graver

University of Groningen

NETHERLANDS

View details

Sarah Pringle

Assistant Professor

University Medical Center Groningen

NETHERLANDS

View details

Christian Dejaco

ITALY

View details

Ashok Kumar Kumawat

Senior Lecturer, Associate professor in Biomedicine

Örebro university

SWEDEN

View details

Priscilla Kamphuis

University Medical Center Groningen

NETHERLANDS

View details

Dan Robbins

Anglia Ruskin University

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Yannick van Sleen

Research Interests

Explore related searches

Contact this professor

Articles (15)

Distinct landscapes of fibroblast subtypes in arteries of patients with giant cell arteritis

IL-2 mediates human bystander CD8+ T-cell responses to innate immune signals

Effects of ageing and frailty on circulating monocyte and dendritic cell subsets

Altered Plasma Levels and Tissue Expression of Fibroblast Activation Protein Alpha in Giant Cell Arteritis

Effect of DMARDs on the immunogenicity of vaccines

Humoral SARS–CoV‐2 Vaccine Responses in Patients With Giant Cell Arteritis and Polymyalgia Rheumatica: Decay After Primary Vaccination and Effects of the Booster

Disease stratification in GCA and PMR: state of the art and future perspectives

Indication of Activated Senescence Pathways in the Temporal Arteries of Patients With Giant Cell Arteritis

Clonal hematopoiesis and UBA1 mutations in individuals with biopsy-proven giant cell arteritis and population-based controls

Angiopoietin-2/-1 ratios and MMP-3 levels as an early warning sign for the presence of giant cell arteritis in patients with polymyalgia rheumatica

Humoral and cellular SARS-CoV-2 vaccine responses in patients with giant cell arteritis and polymyalgia rheumatica

Comment on: Plasma Pyruvate Kinase M2 as a marker of vascular inflammation in giant cell arteritis: reply

Plasma Pyruvate Kinase M2 as a marker of vascular inflammation in giant cell arteritis

Immunogenicity and safety of COVID-19 vaccination in patients with primary Sjögren’s syndrome

Need and value of targeted immunosuppressive therapy in giant cell arteritis

Collaborators (6)

Jacoba Graver

Sarah Pringle

Christian Dejaco

Ashok Kumar Kumawat

Priscilla Kamphuis

Dan Robbins

Make your next move.